新力控股集團(02103.HK)發售價每股3.98港元 預期11月15日上市
格隆匯11月14日丨新力控股集團(02103.HK)公佈,發售約5.29億股,其中香港發售3756.9萬股,國際發售4.92億股;發售價每股3.98港元;每手買1,000股;預期11月15日上市。
公告顯示,香港公開發售認購不足,相當於香港公開發售項下初步可供認購香港發售股份總數的約0.71倍。
國際發售獲輕微超額認購,相當於國際發售項下初步可供認購國際發售股份總數的約1.66倍。
公告稱,所得款項淨額約為19.64億港元。其中,約60%用於現有項目開發建設;約30%用於償還項目發展的部分現有計息借款;約10%用於一般業務營運及營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.